Scott Michael Palmer Jr.

Journal article Am J Respir Cell Mol Biol · May 2012 Featured Publication Chemokines and chemokine receptors have been implicated in the pathogenesis of bronchiolitis. CXCR3 ligands (CXCL10, CXCL9, and CXCL11) were elevated in patients with bronchiolitis obliterans syndrome (BOS) and chronic allorejection. Studies also suggested ... Full text Link to item Cite

Bronchial and bronchiolar fibrosis in rats exposed to 2,3-pentanedione vapors: implications for bronchiolitis obliterans in humans.

Journal article Toxicol Pathol · April 2012 Featured Publication 2,3-Pentanedione (PD) is a component of artificial butter flavorings. The use of PD is increasing since diacetyl, a major butter flavorant, was associated with bronchiolitis obliterans (BO) in workers and has been removed from many products. Because the to ... Full text Link to item Cite

Is prevention the best treatment? CMV after lung transplantation.

Journal article Am J Transplant · March 2012 Featured Publication Cytomegalovirus (CMV) is the most prevalent opportunistic infection that occurs in lung-transplant recipients. In addition to its direct morbidity, multiple studies have demonstrated that CMV, in particular CMV pneumonia, is associated with an increased ri ... Full text Link to item Cite

Spirometrically significant acute rejection increases the risk for BOS and death after lung transplantation.

Journal article Am J Transplant · March 2012 Featured Publication Acute rejection (AR) is a common complication following lung transplantation and is an established risk factor for bronchiolitis obliterans syndrome (BOS). AR clinical presentation varies considerably and is sometimes associated with an acute decrease in f ... Full text Link to item Cite

Protective role of T-bet and Th1 cytokines in pulmonary graft-versus-host disease and peribronchiolar fibrosis.

Journal article Am J Respir Cell Mol Biol · February 2012 Featured Publication T-box expressed in T cells (T-bet) is a critical transcription factor for T helper (Th) 1 responses. Although Th1 cells are thought to contribute to certain alloimmune responses, their role in pulmonary graft-versus-host disease (GVHD) is uncertain. We hav ... Full text Link to item Cite

Stress and coping in caregivers of patients awaiting solid organ transplantation.

Journal article Clin Transplant · 2012 Featured Publication Caregivers for patients undergoing solid organ transplantation play an essential role in the process of transplantation. However, little is known about stress and coping among these caregivers. Six hundred and twenty-one primary caregivers of potential can ... Full text Link to item Cite

Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study.

Journal article Am J Respir Crit Care Med · November 1, 2011 Featured Publication RATIONALE: Obesity has been linked to acute lung injury and is a risk factor for early mortality after lung transplantation. OBJECTIVES: To examine the associations of obesity and plasma adipokines with the risk of primary graft dysfunction after lung tran ... Full text Link to item Cite

Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis.

Journal article Am J Transplant · November 2011 Featured Publication Primary graft dysfunction (PGD) after lung transplantation may result from ischemia reperfusion injury (IRI). The innate immune response to IRI may be mediated by Toll-like receptor and IL-1-induced long pentraxin-3 (PTX3) release. We hypothesized that ele ... Full text Link to item Cite

The state of genome-wide association studies in pulmonary disease: a new perspective.

Journal article Am J Respir Crit Care Med · October 15, 2011 Featured Publication With rapid advances in our knowledge of the human genome and increasing availability of high-throughput investigative technology, genome-wide association (GWA) studies have recently gained marked popularity. As an unbiased approach to identifying genomic r ... Full text Link to item Cite

Long-term efficacy and safety of 12 months of valganciclovir prophylaxis compared with 3 months after lung transplantation: a single-center, long-term follow-up analysis from a randomized, controlled cytomegalovirus prevention trial.

Journal article J Heart Lung Transplant · September 2011 Featured Publication BACKGROUND: The optimal approach to cytomegalovirus (CMV) prevention after lung transplantation is controversial. We recently completed a prospective, randomized, placebo-controlled study of CMV prevention in lung transplantation that demonstrated the shor ... Full text Link to item Cite

Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis.

Journal article Chest · August 2011 Featured Publication BACKGROUND: Serum levels of surfactant protein D (SP-D) have been suggested as reflecting epithelial damage in acute lung injury, COPD, and idiopathic pulmonary fibrosis (IPF). However, little is known about SP-D levels in the setting of lung transplantati ... Full text Link to item Cite

Bronchiolitis obliterans syndrome: the final frontier for lung transplantation.

Journal article Chest · August 2011 Featured Publication Bronchiolitis obliterans syndrome (BOS) is a form of chronic lung allograft dysfunction that affects a majority of lung transplant recipients and is the principal factor limiting long-term transplant survival. BOS is characterized by progressive airflow ob ... Full text Link to item Cite

Acute allograft rejection: cellular and humoral processes.

Journal article Clin Chest Med · June 2011 Featured Publication Acute cellular rejection affects greater than one-third of lung transplant recipients. Alloreactive T-lymphocytes constitute the basis of lung allograft rejection. Recent evidence supports a more complex immune response to the allograft. Interaction betwee ... Full text Link to item Cite

Innate immune activation potentiates alloimmune lung disease independent of chemokine (C-X-C motif) receptor 3.

Journal article J Heart Lung Transplant · June 2011 Featured Publication BACKGROUND: Pulmonary graft-versus-host disease (GVHD) after hematopoietic cell transplant (HCT) and allograft rejection after lung transplant are parallel immunologic processes that lead to significant morbidity and mortality. Our murine model of pulmonar ... Full text Link to item Cite

In pursuit of new experimental models of obliterative bronchiolitis.

Journal article Am J Transplant · May 2011 Featured Publication Full text Link to item Cite

Lung-resident mesenchymal stromal cells. A new player in post-transplant bronchiolitis obliterans syndrome?

Journal article Am J Respir Crit Care Med · April 15, 2011 Featured Publication Full text Link to item Cite

Severe airway epithelial injury, aberrant repair and bronchiolitis obliterans develops after diacetyl instillation in rats.

Journal article PLoS One · March 25, 2011 Featured Publication BACKGROUND: Bronchiolitis obliterans (BO) is a fibrotic lung disease that occurs in a variety of clinical settings, including toxin exposures, autoimmunity and lung or bone marrow transplant. Despite its increasing clinical importance, little is known rega ... Full text Link to item Cite

Polyfunctional cytomegalovirus-specific immunity in lung transplant recipients receiving valganciclovir prophylaxis.

Journal article Am J Transplant · March 2011 Featured Publication Cytomegalovirus (CMV) is a common opportunistic infection after lung transplant. Despite effective antiviral medications to treat CMV, invasive CMV disease contributes to lung allograft dysfunction and worse survival. Efforts to prevent CMV have led to the ... Full text Link to item Cite

Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction.

Journal article Am J Transplant · March 2011 Featured Publication Primary graft dysfunction (PGD) is the leading cause of early posttransplant morbidity and mortality after lung transplantation. Clara cell secretory protein (CC16) is produced by the nonciliated lung epithelium and may serve as a plasma marker of epitheli ... Full text Link to item Cite

Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients.

Journal article Am J Respir Crit Care Med · September 15, 2010 Featured Publication RATIONALE: Despite the importance of bronchiolitis obliterans syndrome (BOS) in lung transplantation, little is known regarding the factors that influence survival after the onset of this condition, particularly among bilateral transplant recipients. OBJEC ... Full text Link to item Cite

Gastroesophageal reflux and altered motility in lung transplant rejection.

Journal article Neurogastroenterol Motil · August 2010 Featured Publication BACKGROUND: Lung transplantation has become an effective therapeutic option for selected patients with end stage lung disease. Long-term survival is limited by chronic rejection manifest as bronchiolitis obliterans syndrome (BOS). The aspiration of gastric ... Full text Link to item Cite

Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation.

Journal article Am J Respir Crit Care Med · June 15, 2010 Featured Publication RATIONALE: Cytomegalovirus pneumonitis is one of the most prevalent opportunistic infections after lung transplantation. Early studies reported that cytomegalovirus pneumonitis was a risk factor for chronic allograft dysfunction. More recently, in the era ... Full text Link to item Cite

Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial.

Journal article Ann Intern Med · June 15, 2010 Featured Publication BACKGROUND: Cytomegalovirus (CMV) is the most prevalent opportunistic infection after lung transplantation. Current strategies do not prevent CMV in most at-risk patients. OBJECTIVE: To determine whether extending prophylaxis with oral valganciclovir from ... Full text Link to item Cite

Lung transplantation in advanced COPD: is it worth it?

Journal article Semin Respir Crit Care Med · June 2010 Featured Publication Chronic obstructive pulmonary disease (COPD) is a condition of progressive airflow obstruction occurring primarily as a result of tobacco use that accounts for substantial worldwide morbidity and mortality. Medical therapy, with the exception of oxygen and ... Full text Link to item Cite

Acute cellular rejection and humoral sensitization in lung transplant recipients.

Journal article Semin Respir Crit Care Med · April 2010 Featured Publication Despite the recent development of many new immunosuppressive agents for use in transplantation, acute cellular and humoral rejection represent extremely prevalent and serious complications after lung transplantation. Acute cellular rejection, defined as pe ... Full text Link to item Cite

Diagnosis and outcome of early pleural space infection following lung transplantation.

Journal article Chest · February 2009 Featured Publication BACKGROUND: Despite the frequent occurrence of pleural effusions in lung transplant recipients, little is known about early posttransplant pleural space infections. We sought to determine the predictors and clinical significance of pleural infection in thi ... Full text Link to item Cite

Acute rejection and humoral sensitization in lung transplant recipients.

Journal article Proc Am Thorac Soc · January 15, 2009 Featured Publication Despite the recent introduction of many improved immunosuppressive agents for use in transplantation, acute rejection affects up to 55% of lung transplant recipients within the first year after transplant. Acute lung allograft rejection is defined as periv ... Full text Link to item Cite

Successful bilateral lung transplantation for lymphangiomatosis.

Journal article Am J Transplant · September 2008 Featured Publication Lymphangiomatosis is a rare disease of lymphatic proliferation for which no adequate treatment is known. We report the first successful case of bilateral lung transplantation for the treatment of end-stage pulmonary lymphangiomatosis. A successful outcome ... Full text Link to item Cite

Baseline 6-min walk distance predicts survival in lung transplant candidates.

Journal article Am J Transplant · July 2008 Featured Publication In a large, prospectively followed, two-center cohort of patients listed for lung transplantation (n = 376), we used Cox proportional hazards models to determine the importance of baseline 6-min walk distance (6MWD) in predicting patient survival. 6MWD use ... Full text Link to item Cite

Respiratory toxicity of diacetyl in C57BL/6 mice.

Journal article Toxicol Sci · May 2008 Featured Publication Diacetyl, a component of artificial butter flavoring, is a potential etiological agent of obliterative bronchiolitis (OB); however, the toxic dose and mechanisms of toxicity remain controversial. We evaluated the respiratory toxicity of diacetyl in a murin ... Full text Link to item Cite

A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.

Journal article J Heart Lung Transplant · December 2007 Featured Publication BACKGROUND: Cytomegalovirus (CMV) disease is a major cause of morbidity and mortality after lung transplantation despite ganciclovir prophylaxis. The emergence of ganciclovir-resistant CMV in lung transplant patients has been reported, although the optimal ... Full text Link to item Cite

Alemtuzumab in the treatment of refractory acute rejection and bronchiolitis obliterans syndrome after human lung transplantation.

Journal article Am J Transplant · December 2007 Featured Publication Despite substantial improvements in early survival after lung transplantation, refractory acute rejection (RAR) and bronchiolitis obliterans syndrome (BOS) remain major contributors to transplant-related morbidity and mortality. We have utilized alemtuzuma ... Full text Link to item Cite

Genetic regulation of rejection and survival following human lung transplantation by the innate immune receptor CD14.

Journal article Am J Transplant · March 2007 Featured Publication We have developed the hypothesis that genetic polymorphisms which alter the expression or function of innate immune receptors contribute to the marked interindividual differences in the onset and severity of lung transplant rejection. In this analysis, we ... Full text Link to item Cite

Cytokine gene polymorphisms are not associated with bronchiolitis obliterans syndrome or survival after lung transplant.

Journal article J Heart Lung Transplant · November 2006 Featured Publication BACKGROUND: Cytokine polymorphisms are inconsistently associated with transplant rejection and other adverse outcomes. To address this controversy, we evaluated cytokine single nucleotide polymorphisms (SNPs) in a lung transplant cohort. METHODS: All patie ... Full text Link to item Cite

High frequency of bronchogenic carcinoma after single-lung transplantation.

Journal article J Heart Lung Transplant · November 2006 Featured Publication BACKGROUND: Lung transplantation is a commonly employed therapy in the treatment of patients with advanced lung diseases related to tobacco use. Little is known about the long-term incidence or risk factors for primary lung cancer after lung transplantatio ... Full text Link to item Cite

Mycobacterium abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient.

Journal article J Heart Lung Transplant · August 2006 Featured Publication Mycobacterial infections are increasingly recognized in cystic fibrosis (CF) patients before transplant; however, knowledge about the clinical significance or spectrum of infections observed with mycobacterial infections in lung transplant recipients is st ... Full text Link to item Cite

Telephone-based coping skills training for patients awaiting lung transplantation.

Journal article J Consult Clin Psychol · June 2006 Featured Publication Impaired quality of life is associated with increased mortality in patients with advanced lung disease. Using a randomized controlled trial with allocation concealment and blinded outcome assessment at 2 tertiary care teaching hospitals, the authors random ... Full text Link to item Cite

Psychosocial issues in the assessment and management of patients undergoing lung transplantation.

Journal article Chest · May 2006 Featured Publication This review examines psychosocial issues among lung transplant patients from the time of assessment through the posttransplant period. Although psychological factors are recognized as being important in the transplant evaluation, no standard approach to ps ... Full text Link to item Cite

Pathologic correlates of bronchiolitis obliterans syndrome in pulmonary retransplant recipients.

Journal article Chest · April 2006 Featured Publication RATIONALE: The main hindrance to long-term success of lung transplantation is bronchiolitis obliterans syndrome (BOS), generally thought to be a manifestation of chronic allograft rejection. BOS is associated histologically with epithelial injury, bronchoc ... Full text Link to item Cite

Successful bilateral lung transplant outcomes in recipients 61 years of age and older.

Journal article Transplantation · March 27, 2006 Featured Publication BACKGROUND: Controversy exists regarding the optimal use of bilateral lung transplant (BLT) in older recipients in diseases where either single or bilateral transplant is appropriate. International Society for Heart and Lung Transplant (ISHLT) guidelines s ... Full text Link to item Cite

Critical care perspective on immunotherapy in lung transplantation.

Journal article J Intensive Care Med · 2006 Featured Publication Lung transplantation is now a viable therapeutic option in the care of patients with advanced pulmonary parenchymal or pulmonary vascular disease. Lung transplantation, however, with chronic posttransplant immunosuppression, creates a uniquely vulnerable p ... Full text Link to item Cite

Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation.

Journal article Clin Transplant · 2006 Featured Publication BACKGROUND: Although innate immunity is crucial to host defense against pathogens, the extent to which innate immune mechanisms participate in the rejection of allogenic tissues in humans is unknown. We hypothesize that activation of innate immunity throug ... Full text Link to item Cite

Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation.

Journal article J Heart Lung Transplant · November 2005 Featured Publication Innate immunity represents the first line of defense against microbial invasion. Recent studies have determined that a group of germline-encoded receptors, termed Toll-like receptors (TLRs), are critical for recognizing foreign motifs on microbial organism ... Full text Link to item Cite

Innate immunity influences long-term outcomes after human lung transplant.

Journal article Am J Respir Crit Care Med · April 1, 2005 Featured Publication RATIONALE: Lung transplantation is characterized by very high rates of acute and chronic allograft rejection. We hypothesize that activation of innate immunity augments adaptive immunity, leading to rejection after lung transplantation. In support of this ... Full text Link to item Cite

Atrial fibrillation after pulmonary transplant.

Journal article Chest · August 2004 Featured Publication BACKGROUND: Although atrial fibrillation or flutter (AF) is thought to occur commonly after pulmonary transplantation, little is known about the epidemiology, risk factors, or clinical significance of arrhythmia in this population. The aim of the current s ... Full text Link to item Cite

Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir.

Journal article Clin Transplant · April 2004 Featured Publication Cytomegalovirus (CMV) is a common opportunistic infection in lung transplant recipients. Despite the use of early post-operative intravenous ganciclovir, most high-risk patients develop CMV infection. We conducted this retrospective study to determine the ... Full text Link to item Cite

Outcome of lung transplant patients admitted to the medical ICU.

Journal article Chest · March 2004 Featured Publication INTRODUCTION: Lung transplantation is an acceptable treatment option for end-stage lung disease. Short-term survival has improved, but lung transplant recipients remain at high risk for a variety of complications that can necessitate care in an ICU. Little ... Full text Link to item Cite

Critical care aspects of lung transplantation.

Journal article J Intensive Care Med · 2004 Featured Publication Lung transplantation currently is the preferred treatment option for a variety of end-stage pulmonary diseases. Remarkable progress has occurred through refinements in technique and improved understanding of transplant immunology and microbiology. As a res ... Full text Link to item Cite

Lung transplantation exacerbates gastroesophageal reflux disease.

Journal article Chest · November 2003 Featured Publication INTRODUCTION: A high prevalence of gastroesophageal reflux (GER) has been reported in lung transplant recipients and is possibly linked to the development of bronchiolitis obliterans syndrome. The etiology of posttransplant GER remains unknown but may occu ... Full text Link to item Cite

Psychiatric disorder and quality of life in patients awaiting lung transplantation.

Journal article Chest · November 2003 Featured Publication STUDY OBJECTIVE: To examine the relationship between psychiatric comorbidity and quality of life in patients awaiting lung transplantation. SETTING: Duke University Medical Center/Lung Transplantation Program. PARTICIPANTS: One hundred patients with end-st ... Full text Link to item Cite

Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients.

Journal article Chest · October 2003 Featured Publication INTRODUCTION: Posttransplant lymphoproliferative disorder (PTLD) is a relatively infrequent but devastating complication that occurs after solid-organ transplantation. Although the optimal treatment for this condition is unknown, rituximab, a murine/human ... Full text Link to item Cite

The role of innate immunity in acute allograft rejection after lung transplantation.

Journal article Am J Respir Crit Care Med · September 15, 2003 Featured Publication Although innate immunity is crucial to pulmonary host defense and can initiate immune and inflammatory responses independent of adaptive immunity, it remains unstudied in the context of transplant rejection. To investigate the role of innate immunity in th ... Full text Link to item Cite

Gastroesophageal reflux disease in lung transplant recipients.

Journal article Clin Transplant · August 2003 Featured Publication BACKGROUND: Chronic allograft dysfunction after lung transplantation contributes to poor long-term survival. A link between gastric aspiration and post-transplant lung dysfunction has been suggested, but little is known about the significance of gastroesop ... Full text Link to item Cite

Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation.

Journal article J Thorac Cardiovasc Surg · March 2003 Featured Publication OBJECTIVES: Bronchiolitis obliterans is the greatest limitation to the long-term applicability of lung transplantation. Although alloimmune events are important, nonimmune events, such as gastroesophageal reflux, might contribute to lung injury and the dev ... Full text Link to item Cite

Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients?

Journal article Chest · October 2002 Featured Publication STUDY OBJECTIVES: Lung transplantation continues to be limited by the development of chronic allograft dysfunction in the form of bronchiolitis obliterans syndrome (BOS). The effect of a transplant operation on patients with BOS has not been well-studied, ... Full text Link to item Cite

Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.

Journal article Transplantation · September 27, 2002 Featured Publication BACKGROUND: Chronic allograft rejection manifested as bronchiolitis obliterans syndrome (BOS) is the leading cause of late death after lung transplantation. Although increasing evidence suggests an association between anti-human leukocyte antigens (HLA) an ... Full text Link to item Cite

Outcome of lung transplantation in patients with mycetomas.

Journal article Chest · January 2002 Featured Publication BACKGROUND: Lung transplantation has become an acceptable treatment option for many end-stage lung diseases. Pulmonary mycetomas are found in patients with end-stage lung diseases, especially sarcoidosis. The clinical course and long-term outcome of these ... Full text Link to item Cite

Sublingual tacrolimus for immunosuppression in lung transplantation: a potentially important therapeutic option in cystic fibrosis.

Journal article Am J Respir Med · 2002 Featured Publication Lung transplantation has emerged as an option to prolong and increase the quality of life in patients with end-stage pulmonary lung disease. In lung transplant recipients, because of the high potential for acute and chronic allograft rejection, optimal sel ... Full text Link to item Cite

Safety of aerosolized amphotericin B lipid complex in lung transplant recipients.

Journal article Transplantation · August 15, 2001 Featured Publication BACKGROUND: Fungal infections remain an important cause of morbidity and mortality in lung transplant recipients. Aerosolized amphotericin B lipid complex (ABLC) may be more efficacious than conventional amphotericin B in the prevention of fungal infection ... Full text Link to item Cite

Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection.

Journal article Transplantation · June 27, 2001 Featured Publication BACKGROUND: Although the use of mycophenolate mofetil (MMF) has reduced the incidence of acute rejection in heart and kidney allograft recipients, its role in lung transplantation remains controversial. Therefore, we conducted a randomized, prospective, op ... Full text Link to item Cite

Influenza pneumonia in lung transplant recipients: clinical features and association with bronchiolitis obliterans syndrome.

Journal article Chest · April 2001 Featured Publication Influenza infection is increasingly recognized to cause significant morbidity and mortality in the community, especially in pediatric patients and elderly persons. Influenza infection, however, has not been well described among thoracic organ transplant re ... Full text Link to item Cite

Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation.

Journal article Chest · October 2000 Featured Publication Gastroesophageal reflux (GER) is increasingly recognized as contributing to a number of pulmonary disorders. The relationship of GER to pulmonary allograft dysfunction after lung transplantation is unknown. In this report, we describe a lung transplant rec ... Full text Link to item Cite

Significance of blood stream infection after lung transplantation: analysis in 176 consecutive patients.

Journal article Transplantation · June 15, 2000 Featured Publication BACKGROUND: Although infection is a leading cause of death after lung transplantation, very little is known about the incidence, epidemiology, and clinical significance of bloodstream infections in lung transplant recipients. METHODS: All blood cultures we ... Full text Link to item Cite

Anastomotic infections in lung transplant recipients.

Journal article Ann Transplant · 2000 Featured Publication OBJECTIVES: Anastomotic infections are an uncommon but potentially devastating complication after lung transplantation. The incidence, microbiology, predisposing factors, and clinical outcomes of anastomotic infections have not been well described. METHODS ... Link to item Cite

Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: results of a randomized, prospective study.

Journal article Chest · July 1999 Featured Publication STUDY OBJECTIVES: The efficacy of antithymocyte induction therapy in lung transplantation is controversial, and its use varies from center to center. We hypothesized that rabbit antithymocyte globulin (RATG) induction therapy would decrease acute rejection ... Full text Link to item Cite

Candidal anastomotic infection in lung transplant recipients: successful treatment with a combination of systemic and inhaled antifungal agents.

Journal article J Heart Lung Transplant · October 1998 Featured Publication Anastomotic infection is an uncommon but potentially life-threatening complication after lung transplantation. We recently encountered three lung transplant recipients with invasive candidal anastomotic infection. Two patients were admitted with dyspnea an ... Link to item Cite

Community respiratory viral infection in adult lung transplant recipients.

Journal article Chest · April 1998 Featured Publication STUDY OBJECTIVE: To define the epidemiology, clinical manifestations, and long-term complications of respiratory viral infections in adult lung transplant recipients. DESIGN: Retrospective review of the records of 122 adult lung transplant recipients over ... Full text Link to item Cite